These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
402 related items for PubMed ID: 11530957
21. [Inhaled budesonide for chronic obstructive pulmonary disease]. Weiner P, Zamir D, Beckerman M. Harefuah; 1997 Jun 01; 132(11):756-9, 823. PubMed ID: 9223815 [Abstract] [Full Text] [Related]
22. [Changes in some ventilation and respiration parameters in patients with chronic obstructive lung disease in prospective longitudinal study]. Mayer M, Dúbrava I, Petrîk V, Mayerová S, Bielik L. Z Erkr Atmungsorgane; 1982 Jun 01; 159(3):252-8. PubMed ID: 7184218 [Abstract] [Full Text] [Related]
23. The effect of conductive ventilation heterogeneity on diffusing capacity measurement. Verbanck S, Schuermans D, Van Malderen S, Vincken W, Thompson B. J Appl Physiol (1985); 2008 Apr 01; 104(4):1094-100. PubMed ID: 18276899 [Abstract] [Full Text] [Related]
24. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. Lindberg A, Szalai Z, Pullerits T, Radeczky E. Respirology; 2007 Sep 01; 12(5):732-9. PubMed ID: 17875063 [Abstract] [Full Text] [Related]
25. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Vestbo J, Sørensen T, Lange P, Brix A, Torre P, Viskum K. Lancet; 1999 May 29; 353(9167):1819-23. PubMed ID: 10359405 [Abstract] [Full Text] [Related]
26. A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin. Dimopoulou I, Galani H, Dafni U, Samakovii A, Roussos C, Dimopoulos MA. Cancer; 2002 Jan 15; 94(2):452-8. PubMed ID: 11900231 [Abstract] [Full Text] [Related]
27. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease. Ferguson MK, Vigneswaran WT. Ann Thorac Surg; 2008 Apr 15; 85(4):1158-64; discussion 1164-5. PubMed ID: 18355489 [Abstract] [Full Text] [Related]
28. [Changes in pulmonary function in SARS patients during the three-year convalescent period]. Liu YX, Ye YP, Zhang P, Chen J, Ye H, He YH, Li N. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep 15; 19(9):536-8. PubMed ID: 17767822 [Abstract] [Full Text] [Related]
29. Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival. Borst GR, De Jaeger K, Belderbos JS, Burgers SA, Lebesque JV. Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):639-44. PubMed ID: 15936539 [Abstract] [Full Text] [Related]
30. Melatonin administration acutely decreases the diffusing capacity of carbon monoxide in human lungs. Vardar SA, Altun GD, Günerbuyuk C, Hatipoglu ON, Mert S, Kaymak K. Respiration; 2006 Jul 01; 73(4):509-13. PubMed ID: 16195665 [Abstract] [Full Text] [Related]
31. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD. Jensen D, Amjadi K, Harris-McAllister V, Webb KA, O'Donnell DE. Thorax; 2008 Jul 01; 63(7):606-13. PubMed ID: 18250181 [Abstract] [Full Text] [Related]
32. [Measuring breathing pattern in patients with chronic obstructive pulmonary disease by electrical impedance tomography]. Balleza M, Calaf N, Feixas T, González M, Antón D, Riu PJ, Casan P. Arch Bronconeumol; 2009 Jul 01; 45(7):320-4. PubMed ID: 19497652 [Abstract] [Full Text] [Related]
33. Controlled trial of inhaled fluticasone propionate in moderate to severe COPD. Thompson WH, Carvalho P, Souza JP, Charan NB. Lung; 2002 Jul 01; 180(4):191-201. PubMed ID: 12391509 [Abstract] [Full Text] [Related]
34. Serial pulmonary function in patients with acute heart failure. Light RW, George RB. Arch Intern Med; 1983 Mar 01; 143(3):429-33. PubMed ID: 6830378 [Abstract] [Full Text] [Related]
35. Inhaled sodium pyruvate improved FEV1 and decreased expired breath levels of nitric oxide in patients with chronic obstructive pulmonary disease. Votto JJ, Bowen JB, Barton RW, Thrall RS. J Aerosol Med Pulm Drug Deliv; 2008 Dec 01; 21(4):329-34. PubMed ID: 18800883 [Abstract] [Full Text] [Related]
36. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases. Majumdar S, Sen S, Mandal SK. J Indian Med Assoc; 2007 Oct 01; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952 [Abstract] [Full Text] [Related]
37. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study. Kunisaki KM, Rice KL, Janoff EN, Rector TS, Niewoehner DE. Ther Adv Respir Dis; 2008 Apr 01; 2(2):55-64. PubMed ID: 19124359 [Abstract] [Full Text] [Related]
38. Response to corticosteroids in chronic airflow obstruction: relationship to emphysema and airways collapse. Weir DC, Gove RI, Robertson AS, Burge PS. Eur Respir J; 1991 Nov 01; 4(10):1185-90. PubMed ID: 1804665 [Abstract] [Full Text] [Related]
39. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities]. Beeh KM, Beier J, Buhl R, Stark-Lorenzen P, Gerken F, Metzdorf N, ATEM-Studiengruppe. Pneumologie; 2006 Jun 01; 60(6):341-6. PubMed ID: 16761228 [Abstract] [Full Text] [Related]
40. Gas exchange response to naloxone in chronic obstructive pulmonary disease with hypercapnic respiratory failure. Roca J, Montserrat JM, Rodriguez-Roisin R, Guitart R, Torres A, Agusti AG, Wagner PD. Bull Eur Physiopathol Respir; 1987 Jun 01; 23(3):249-54. PubMed ID: 3117149 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]